ArticleJournal of clinical medicine2026

PD-L1 Expression as a Predictor of Time to Progression in Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Single-Center Study.

Marija Simonovska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.